Figure 6.
OS according to immunological parameters of the cohort in which patients were censored at the day of allogeneic HSCT. (A) OS according to higher or lower percentages of Tax-CTLs within all lymphocytes. (B) OS according to CMV-CTL percentages in all lymphocytes. (C) OS according to percentages of Tax-CTLs within CD8+ lymphocytes. (D) OS according to percentages of CMV-CTLs within CD8+ lymphocytes. (E) OS according to percentages of CD2-CD19+ B cells within lymphocytes. (F) OS according to CD3+CD8+ T cell levels. (G) OS according to CD16+CD56+ NK cell levels. (H) OS according to CD11c+ monocyte levels.

OS according to immunological parameters of the cohort in which patients were censored at the day of allogeneic HSCT. (A) OS according to higher or lower percentages of Tax-CTLs within all lymphocytes. (B) OS according to CMV-CTL percentages in all lymphocytes. (C) OS according to percentages of Tax-CTLs within CD8+ lymphocytes. (D) OS according to percentages of CMV-CTLs within CD8+ lymphocytes. (E) OS according to percentages of CD2-CD19+ B cells within lymphocytes. (F) OS according to CD3+CD8+ T cell levels. (G) OS according to CD16+CD56+ NK cell levels. (H) OS according to CD11c+ monocyte levels.

Close Modal

or Create an Account

Close Modal
Close Modal